Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Net Cash Flow (2020 - 2026)

PROCEPT BioRobotics has reported Net Cash Flow over the past 7 years, most recently at -$40.8 million for Q1 2026.

  • Quarterly Net Cash Flow fell 133.01% to -$40.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$70.4 million through Mar 2026, down 177.73% year-over-year, with the annual reading at -$47.1 million for FY2025, 161.63% down from the prior year.
  • Net Cash Flow was -$40.8 million for Q1 2026 at PROCEPT BioRobotics, down from -$7.7 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $137.4 million in Q3 2023 and troughed at -$40.9 million in Q1 2023.
  • The 5-year median for Net Cash Flow is -$17.3 million (2024), against an average of -$3.3 million.
  • The largest YoY upside for Net Cash Flow was 767.36% in 2023 against a maximum downside of 140.58% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$27.4 million in 2022, then decreased by 12.0% to -$30.6 million in 2023, then surged by 546.98% to $137.0 million in 2024, then crashed by 105.65% to -$7.7 million in 2025, then crashed by 427.58% to -$40.8 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Net Cash Flow are -$40.8 million (Q1 2026), -$7.7 million (Q4 2025), and -$8.4 million (Q3 2025).